A detailed history of Angelo Gordon & Co., L.P. transactions in Catalent, Inc. stock. As of the latest transaction made, Angelo Gordon & Co., L.P. holds 60,000 shares of CTLT stock, worth $3.54 Million. This represents 2.71% of its overall portfolio holdings.

Number of Shares
60,000
Holding current value
$3.54 Million
% of portfolio
2.71%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$53.58 - $57.02 $3.21 Million - $3.42 Million
60,000 New
60,000 $3.37 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Angelo Gordon & Co., L.P. Portfolio

Follow Angelo Gordon & Co., L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Angelo Gordon & Co., L.P., based on Form 13F filings with the SEC.

News

Stay updated on Angelo Gordon & Co., L.P. with notifications on news.